Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea flag South Korea · Delayed Price · Currency is KRW
20,750
-800 (-3.71%)
At close: Feb 6, 2026

Chabiotech Revenue

Chabiotech had revenue of 318.68B KRW in the quarter ending September 30, 2025, with 17.15% growth. This brings the company's revenue in the last twelve months to 1.20T, up 18.61% year-over-year. In the year 2024, Chabiotech had annual revenue of 1.05T with 9.55% growth.

Revenue (ttm)
1.20T
Revenue Growth
+18.61%
P/S Ratio
1.40
Revenue / Employee
4.31B
Employees
278
Market Cap
1.68T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.05T91.10B9.55%
Dec 31, 2023953.95B109.37B12.95%
Dec 31, 2022844.58B117.11B16.10%
Dec 31, 2021727.48B62.76B9.44%
Dec 31, 2020664.72B130.11B24.34%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PharmaResearch496.03B
Hugel404.19B
Medy-Tox241.80B
MEDIPOST73.59B
Pharmicell23.94B
OliX Pharmaceuticals10.18B
D&D Pharmatech8.36B
Voronoi7.49B
Revenue Rankings